American International Group’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-24,649
| Closed | -$55 | – | 3327 |
|
|
2021
Q1 | $55 | Buy |
24,649
+65
| +0.3% | – | ﹤0.01% | 2962 |
|
|
2020
Q4 | $61 | Sell |
24,584
-414
| -2% | -$1 | ﹤0.01% | 2901 |
|
|
2020
Q3 | $62K | Buy |
24,998
+890
| +4% | +$2.21K | ﹤0.01% | 2791 |
|
|
2020
Q2 | $86K | Buy |
+24,108
| New | +$86K | ﹤0.01% | 2621 |
|
|
2019
Q2 | – | Sell |
-20,649
| Closed | -$41K | – | 3177 |
|
|
2019
Q1 | $41K | Sell |
20,649
-668
| -3% | -$1.33K | ﹤0.01% | 2925 |
|
|
2018
Q4 | $28K | Sell |
21,317
-164
| -0.8% | -$215 | ﹤0.01% | 2992 |
|
|
2018
Q3 | $53K | Buy |
21,481
+387
| +2% | +$955 | ﹤0.01% | 3056 |
|
|
2018
Q2 | $71K | Buy |
21,094
+907
| +4% | +$3.05K | ﹤0.01% | 2908 |
|
|
2018
Q1 | $85K | Sell |
20,187
-1,086
| -5% | -$4.57K | ﹤0.01% | 2736 |
|
|
2017
Q4 | $70K | Buy |
21,273
+2,159
| +11% | +$7.1K | ﹤0.01% | 2863 |
|
|
2017
Q3 | $73K | Buy |
19,114
+1,429
| +8% | +$5.46K | ﹤0.01% | 2746 |
|
|
2017
Q2 | $78K | Buy |
+17,685
| New | +$78K | ﹤0.01% | 2869 |
|
|
2016
Q2 | – | Sell |
-10,115
| Closed | -$25K | – | 4605 |
|
|
2016
Q1 | $25K | Sell |
10,115
-779
| -7% | -$1.93K | ﹤0.01% | 4218 |
|
|
2015
Q4 | $36K | Sell |
10,894
-162
| -1% | -$535 | ﹤0.01% | 4058 |
|
|
2015
Q3 | $38K | Hold |
11,056
| – | – | ﹤0.01% | 4033 |
|
|
2015
Q2 | $14.7K | Buy |
11,056
+739
| +7% | +$983 | ﹤0.01% | 4477 |
|
|
2015
Q1 | $8.67K | Sell |
10,317
-47,496
| -82% | -$39.9K | ﹤0.01% | 4578 |
|
|
2014
Q4 | $23.1K | Buy |
+57,813
| New | +$23.1K | ﹤0.01% | 4269 |
|